Renal replacement therapy for autosomal dominant polycystic kidney disease

? Renal replacement therapy is required when autosomal dominant polycystic kidney disease progresses to end-stage disease.

Hemodialysis is preferred, but peritoneal dialysis can be chosen, but enlarged kidneys reduce effective peritoneal dialysis area, which can affect the effectiveness of peritoneal dialysis. Kidney transplantation is autosomal dominant polycystic kidney disease, an alternative treatment for end-stage kidney disease.

Kidney survival and the incidence of complications after transplantation are similar to those of other kidney transplant populations. Cyst infection, recurrent cyst bleeding, severe hypertension, and large pelvic protrusion are present before kidney transplantation, and nephrectomy can be performed

. Infection is one of the main complications after kidney transplantation in patients with autosomal dominant polycystic kidney disease. Urinary tract infection is the most common, so careful monitoring and early treatment of infection should be carried out after transplantation.